VirExit signs reseller deal for air purification tech

Published 15/05/2025, 20:04
VirExit signs reseller deal for air purification tech

On Thursday, VirExit Technologies, Inc. (OTC:VXIT), an electric lighting and wiring equipment manufacturer with a market capitalization of $3.26 million, announced a significant expansion in its business operations with the execution of a national reseller agreement. The company’s stock has shown remarkable momentum, delivering a 125% return year-to-date, according to InvestingPro data. The agreement, signed on January 21, 2025, with SAGE Industrial Corporation, grants VirExit non-exclusive distribution rights for the AirROS™ air-and-surface purification systems throughout the United States, excluding federal buyers.

This partnership enables VirExit to offer a dual-revenue model that includes high-margin hardware sales and recurring annual service contracts. While InvestingPro analysis indicates the company currently faces challenges with gross profit margins, the new recurring revenue stream could potentially improve profitability metrics. InvestingPro subscribers have access to 8 additional key insights about VXIT’s financial health and market position. These services encompass filter replacements, remote monitoring, and preventive maintenance. The company projects a revenue of $196,721 from five pilot installations in the second half of FY 2025, $786,885 in FY 2026 from 20 installations, and $1.57M in FY 2027 from 40 new installations, with significant contributions from recurring service contracts.

The AirROS™ system, which utilizes patented reactive oxygen species (ROS) technology, has been validated by multiple lab studies, including a peer-reviewed research brief from Scientific Air Solutions. The system has demonstrated over 99.9999% effectiveness in eliminating airborne and surface pathogens within 30 minutes and has shown significant reductions in colony-forming units (CFUs) in real-world installations.

VirExit anticipates capitalizing on the growing indoor air quality (IAQ) market, which is expected to surpass $8 billion by 2028. The company plans to target various verticals including healthcare, education, and residential sectors. Moreover, VirExit is set to launch the AirROS™ Home unit in Q4 2025, aiming at the $2.1 billion U.S. residential market.

The company’s technology is safeguarded by patents and supported by ongoing research and development efforts, contributing to a strong competitive advantage. VirExit’s strategic approach is further outlined in the March 2025 AirROS™ investor pitch deck, which provides additional details on financial positioning and market strategy. With average daily trading volume of 5.34 million shares and significant price momentum showing a 20% return in the past week, investors seeking detailed analysis can access comprehensive metrics and valuations through InvestingPro’s advanced analytics platform.

The information provided is based on a press release statement and the full details of the agreement, third-party lab reports, case studies, and the investor pitch deck are available as exhibits to the SEC filing. This report contains forward-looking statements, and actual results may differ materially from those projected. Interested parties are encouraged to refer to filings with OTC Markets for a complete discussion of risks.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.